Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Monteiro

Showing results (721-730 of 730) with videos related to

Pageof 73
Sort By:
You have reached the last page of results.This site can display upto 730 results.
Targeted Oncology|June 27, 2023
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 StudyMatteo Santoni, Francesco Massari, Zin W Myint, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2015
Non-bee insects are important contributors to global crop pollinationRomina Rader, Ignasi Bartomeus, Lucas A Garibaldi, et al.
BMC Medicine|August 2, 2019
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
European Urology Oncology|July 22, 2023
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?Matteo Santoni, Sebastiano Buti, Zin W Myint, et al.
The Lancet. Infectious Diseases|July 24, 2018
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Molecular Ecology Resources|March 25, 2011
Permanent genetic resources added to Molecular Ecology Resources Database 1 August 2010-30 September 2010, Ramesh K Aggarwal, Joel Allainguillaume, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2024
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 studyFrancesco Massari, Matteo Santoni, Hideki Takeshita, et al.
Nature Communications|May 15, 2021
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications|April 16, 2021
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications|February 5, 2024
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Pageof 73

Showing results (721-730 of 730) with videos related to

Sort By:
Pageof 73
You have reached the last page of results.This site can display upto 730 results.
Targeted Oncology|June 27, 2023
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 StudyMatteo Santoni, Francesco Massari, Zin W Myint, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2015
Non-bee insects are important contributors to global crop pollinationRomina Rader, Ignasi Bartomeus, Lucas A Garibaldi, et al.
BMC Medicine|August 2, 2019
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
European Urology Oncology|July 22, 2023
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?Matteo Santoni, Sebastiano Buti, Zin W Myint, et al.
The Lancet. Infectious Diseases|July 24, 2018
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Molecular Ecology Resources|March 25, 2011
Permanent genetic resources added to Molecular Ecology Resources Database 1 August 2010-30 September 2010, Ramesh K Aggarwal, Joel Allainguillaume, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2024
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 studyFrancesco Massari, Matteo Santoni, Hideki Takeshita, et al.
Nature Communications|May 15, 2021
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications|April 16, 2021
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications|February 5, 2024
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Pageof 73